Announcement date of notice of general meeting of shareholders: March 26, 2024 |
corporate name | Shutaishen |
Date of announcement | 2024-03-26 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2023 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2023 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2023 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2023 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on 2023 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2024 8.00 Proposal on the Prediction of Connected Transactions of the Company and Subsidiaries in 2024 9.00 Proposal on Absorption and Merger of Wholly owned Subsidiary De Feng Rui 10.00 Proposal on Absorption and Merger of Wholly owned Subsidiary Zhejiang Shutaishen |
Deliberation content | Profit distribution plan, merger and acquisition, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: December 26, 2023 |
corporate name | Shutaishen |
Date of announcement | 2023-12-26 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Extending the Validity Period of the Resolution of the General Meeting of Shareholders on Issuing Shares to Specific Objects in 2022 2.00 Proposal on Requesting the General Meeting of Shareholders of the Company to Extend the Validity Period of Authorizing the Board of Directors to Handle Matters Related to the Issuance of Shares to Specific Targets in 2022 |
Deliberation content | Proposal on additional issuance of new shares |
|
Announcement date of notice of general meeting of shareholders: October 25, 2023 |
corporate name | Shutaishen |
Date of announcement | 2023-10-25 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Closing the Initial Public Offering and Permanently Replenishing the Surplus Raised Capital to Working Capital 2.00 Proposal on Closing of Some Over raised Projects and Permanent Replenishment of Working Capital by Using Some Over raised Funds 3.00 Proposal on the Increase of 2023 Daily Related Transaction Forecast of the Company and Subsidiaries 4.00 Proposal on Change of Registered Capital of the Company 5.00 Proposal on Amending the Articles of Association and Related Systems 5.01 Proposal on Amending the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.02 Proposal on Amending the Administrative Measures for Foreign Investment 5.03 Proposal on Amending the Working System of Independent Directors 5.04 Proposal on Amending the External Guarantee Management System |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: June 12, 2023 |
corporate name | Shutaishen |
Date of announcement | 2023-06-12 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Termination of Some Funded Projects |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: March 20, 2023 |
corporate name | Shutaishen |
Date of announcement | 2023-03-20 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2022 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2022 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2022 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2022 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the 2022 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2023 8.00 Proposal on the Prediction of Connected Transactions of the Company and Subsidiaries in 2023 9.00 Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: December 22, 2022 |
corporate name | Shutaishen |
Date of announcement | 2022-12-22 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the Company's Compliance with the Conditions for Issuing Shares to Specific Objects 2.00 Proposal on the Company's Plan of Issuing Shares to Specific Targets in 2022 2.01 Type and par value of issued shares 2.02 Issuance method and time 2.03 Issuance Object and Subscription Method 2.04 Pricing Base Date, Issue Price and Pricing Principles 2.05 Number of issues 2.06 Use of raised funds 2.07 Restricted period 2.08 Listing place 2.09 Arrangement of accumulated profits before this offering 2.10 Validity period of this issuance resolution 3.00 Proposal on the Plan for the Company to Issue Shares to Specific Targets in 2022 4.00 Proposal on the Analysis Report of the Company's 2022 Share Issuance Scheme to Specific Targets 5.00 Proposal on the Feasibility Analysis Report on the Use of Funds Raised by the Company's Issuance of Shares to Specific Targets in 2022 6.00 Proposal on the Report on the Use of the Fund Raised Previously by the Company 7.00 Proposal on the Company's Issuance of Shares to Specific Targets in 2022 to Dilute Immediate Return and Filling Measures and Commitments of Relevant Subjects 8.00 Proposal on Shareholder Return Planning of the Company in the Next Three Years (2023-2025) 9.00 Proposal on Submitting the General Meeting of Shareholders to Authorize the Board of Directors to Fully Handle Matters Related to the Issuance of Shares to Specific Objects in 2022 |
Deliberation content | Proposal on additional issuance of new shares |
|
Announcement date of notice of general meeting of shareholders: August 23, 2022 |
corporate name | Shutaishen |
Date of announcement | 2022-08-23 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the Increase of 2022 Daily Related Transaction Forecast of the Company and Subsidiaries 2.00 Proposal on Adjusting the Use and Cancellation of the Remaining Shares in the Company's Special Account for Repurchase 3.00 Proposal on By election of Non independent Directors of the 5th Board of Directors 4.00 Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: April 19, 2022 |
corporate name | Shutaishen |
Date of announcement | 2022-04-19 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2021 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2021 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2021 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2021 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the 2021 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2022 8.00 Proposal on Merger of Wholly owned Subsidiaries 9.00 Proposal on Adjusting the Total Investment of Raised Investment Projects 10.00 Proposal on Using Part of Over raised Funds to Permanently Supplement Working Capital 11.00 Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 12.00 Proposal on Submitting the General Meeting of Shareholders to Authorize the Board of Directors to Handle the Issue of Shares to Specific Objects in a Simple Procedure |
Deliberation content | Merger and acquisition, profit distribution plan, annual report (summary) proposal, proposal on additional shares |
|
Announcement date of notice of general meeting of shareholders: July 26, 2021 |
corporate name | Shutaishen |
Date of announcement | 2021-07-26 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the General Election of Non independent Directors of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 1.01 Elect Mr. Zhou Zhiwen as a director of the 5th Board of Directors of the Company 1.02 Elect Mr. Zhang Rongqin as a director of the 5th Board of Directors 1.03 Elect Mr. Yang Lianchun as a director of the 5th Board of Directors 1.04 Electing Ms. Ma Lina as a director of the 5th Board of Directors 2.00 Proposal on the Election of Independent Directors by the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.01 Elect Ms. Sun Ying as the independent director of the 5th Board of Directors 2.02 Elect Mr. Zhao Li as the independent director of the 5th Board of Directors 2.03 Elect Mr. Zhao Jiajun as the independent director of the 5th Board of Directors 3.00 Proposal on the General Election of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.01 Elect Mr. Zhang Hongshan as the supervisor of the 5th Board of Supervisors 3.02 Elect Ms. Li Tao as the supervisor of the 5th Board of Supervisors |
Deliberation content | Proposal on the change of directors |
|
Announcement date of notice of general meeting of shareholders: July 9, 2021 |
corporate name | Shutaishen |
Date of announcement | 2021-07-09 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Adjusting the Number of Board Members 2.00 Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: April 20, 2021 |
corporate name | Shutaishen |
Date of announcement | 2021-04-20 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. in 2020 2.00 Proposal on the 2020 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2020 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2020 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the 2020 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2021 8.00 Proposal on Extending the Validity Period of the Resolution of the General Meeting of Shareholders of Non public Offering Shares and the Validity Period of the Authorization of the General Meeting of Shareholders to the Board of Directors 9.00 Proposal on Amending the Rules of Procedure of the Board of Supervisors 10.00 Proposal on Amending the Rules of Procedure of the General Meeting of Shareholders 11.00 Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal, proposal on new share issuance |
|
Announcement date of notice of general meeting of shareholders: February 9, 2021 |
corporate name | Shutaishen |
Date of announcement | 2021-02-09 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Adjusting the Name, Implementation Content and Implementation Progress of Raised Investment Projects and Lowering the Total Investment of Raised Investment Projects 2.00 Proposal on Using Part of Over raised Funds to Permanently Supplement Working Capital 3.00 Proposal on Signing Related Transaction Framework Agreement with Related Parties 4.00 Proposal on the Prediction of Connected Transactions of the Company and Subsidiaries in 2021 |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: September 2, 2020 |
corporate name | Shutaishen |
Date of announcement | 2020-09-02 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting, soliciting votes |
Topic | 1.00 Proposal on Amending the Articles of Association and Related Systems 1.01 Proposal on Amending the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 1.02 Proposal on Amending the Rules of Procedure of the General Meeting of Shareholders 1.03 Proposal on Amending the Rules of Procedure of the Board of Directors 1.04 Proposal on Amending the Decision making System of Connected Transactions 1.05 Proposal on Amending the External Guarantee Management System 1.06 Proposal on Amending the Administrative Measures for Foreign Investment 1.07 Proposal on Amending the Working System of Independent Directors 1.08 Proposal on Amending the Fund Raising Management System 1.09 Proposal on Amending the Detailed Rules for the Implementation of the Cumulative Voting System 1.10 Proposal on Amending the Remuneration and Performance Appraisal Management System for Directors, Supervisors and Senior Managers 2.00 Proposal on the 2020 Restricted Stock Incentive Plan (Draft) of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. and its Abstract 3.00 Proposal on the Management Measures for the Implementation of the 2020 Restricted Stock Incentive Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on Submitting the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Equity Incentive |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: July 14, 2020 |
corporate name | Shutaishen |
Date of announcement | 2020-07-14 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on Exemption of Relevant Commitments 2.00 Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: April 8, 2020 |
corporate name | Shutaishen |
Date of announcement | 2020-04-08 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the Company's Compliance with the Conditions for Non public Issuance of Shares on the Growth Enterprise Market 2.00 Proposal on the Scheme of Private Equity Issuance on the Growth Enterprise Market 2.01 Type and par value of issued shares 2.02 Issuance method 2.03 Issuance Object and Subscription Method 2.04 Pricing Base Date, Issue Price and Pricing Principles 2.05 Number of issues 2.06 Restricted period 2.07 Arrangement for distribution of accumulated profits of the Company before the issuance 2.08 Listing place 2.09 Amount and purpose of raised funds 2.10 Validity period of this non-public offering resolution 3.00 Proposal on the Plan for non-public offering of A-shares on the GEM in 2020 of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the Argument and Analysis Report on the 2020 GEM Non public Offering of A-shares of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the Feasibility Analysis Report on the Use of Funds Raised from non-public A-share Development on the Growth Enterprise Market in 2020 of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on the Report on the Use of the Fund Raised Previously by Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 7.00 Proposal on the Impact of Dilution of Immediate Return of the Company's Non public Shares on the Growth Enterprise Market in 2020 and the Measures Taken by the Company 8.00 Proposal on the Commitment of Relevant Subjects to Filling Diluted Immediate Return Measures after the Company's non-public offering of A-shares on the GEM in 2020 9.00 Proposal on the Shareholders' Dividend Return Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. in the Next Three Years (2020-2022) 10.00 Proposal on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Fully Handle the Matters Related to the Non public Offering of Shares of the Company |
Deliberation content | Proposal on additional issuance of new shares |
|
Announcement date of notice of general meeting of shareholders: March 17, 2020 |
corporate name | Shutaishen |
Date of announcement | 2020-03-17 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2019 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2019 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on 2019 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2019 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on 2019 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2020 |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of the notice of the general meeting of shareholders: March 4, 2019 |
corporate name | Shutaishen |
Date of announcement | 2019-03-04 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2018 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2018 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2018 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2018 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the 2018 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on Remuneration Plan of Directors and Supervisors in 2019 8.00 Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks 9.00 Proposal on Termination of Some Funded Projects and Adjustment of Total Investment and Implementation Progress of Some Funded Projects 10.00 Proposal on the Change of Registered Capital of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 11.00 Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: September 17, 2018 |
corporate name | Shutaishen |
Date of announcement | 2018-09-17 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Plan on Repurchasing the Company's Shares by Centralized Bidding 1.01 Purpose and purpose of share repurchase 1.02 Way to buy back shares 1.03 Price or price range and pricing principle of repurchased shares 1.04 Type, quantity and proportion of shares to be repurchased 1.05 Total amount of funds to be used for repurchase and source of funds 1.06 Term of Share Repurchase 1.07 Validity of resolutions 2.00 Proposal on Submitting the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Share Repurchase |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: August 27, 2018 |
corporate name | Shutaishen |
Date of announcement | 2018-08-27 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the General Election of Non independent Directors of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 1.01 Elect Mr. Zhou Zhiwen as a director of the 4th Board of Directors of the Company 1.02 Elect Ms. Zhou Yi as a director of the fourth board of directors 1.03 Elect Mr. Gu Zhenqi as a director of the 4th Board of Directors of the Company 1.04 Elect Mr. Chen Hao as a director of the 4th Board of Directors of the Company 1.05 Elect Mr. Zhang Rongqin as a director of the 4th Board of Directors of the Company 1.06 Elect Ms. Ma Lina as a director of the fourth board of directors of the company 2.00 Proposal on the Election of Independent Directors by the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.01 Elect Mr. Zhao Jialiang as the independent director of the fourth board of directors 2.02 Elect Ms. Sun Ying as the independent director of the fourth board of directors 2.03 Elect Mr. Gong Zhaolong as the independent director of the fourth board of directors 3.00 Proposal on the General Election of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.01 Elect Mr. Zhang Hongshan as the supervisor of the fourth Board of Supervisors 3.02 Elect Mr. Ye Qing as the supervisor of the fourth Board of Supervisors 4.00 Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks 5.00 Proposal on the Change of Registered Capital of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Proposal on the change of directors |
|
Announcement date of the notice of the general meeting of shareholders: February 12, 2018 |
corporate name | Shutaishen |
Date of announcement | 2018-02-12 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1.00 Proposal on the 2017 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.00 Proposal on the 2017 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.00 Proposal on the 2017 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4.00 Proposal on the 2017 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5.00 Proposal on the 2017 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6.00 Proposal on Renewing the Employment of Accounting Firm 7.00 Proposal on 2018 Remuneration Plan of Directors and Supervisors 8.00 Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks 9.00 Proposal on the Change of Registered Capital of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 10.00 Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: August 21, 2017 |
corporate name | Shutaishen |
Date of announcement | 2017-08-21 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks 2. Proposal on Change of Registered Capital of the Company 3. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: March 20, 2017 |
corporate name | Shutaishen |
Date of announcement | 2017-03-20 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on the 2016 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2. Proposal on the 2016 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3. Proposal on 2016 Financial Final Account Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4. Proposal on the 2016 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 5. Proposal on 2016 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6. Proposal on the Company's Renewal of Employment of Accounting Firm 7. Proposal on 2017 Remuneration Plan of Directors and Supervisors 8. Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks 9. Proposal on the Change of Registered Capital of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 10. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: September 2, 2016 |
corporate name | Shutaishen |
Date of announcement | 2016-09-02 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting, soliciting votes |
Topic | 1. Proposal on the 2016 Restricted Stock Incentive Plan (Draft) of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. and its Abstract (each sub proposal needs to be voted one by one); 1.1 Determination basis and scope of incentive objects; 1.2 Source, quantity and distribution of restricted shares; 1.3 The validity period, grant date, sales restriction period, lifting of sales restriction arrangement and sales restriction period of the incentive plan; 1.4 The grant price of restricted shares and the method for determining the grant price; 1.5 Conditions for granting and lifting restrictions on sales of restricted shares; 1.6 Adjustment methods and procedures of restricted stock incentive plan; 1.7 Accounting treatment of restricted stocks; 1.8 Implementation procedures of restricted stock incentive plan; 1.9 Rights and obligations of the company/incentive objects; 1.10 Handling of changes in the company/incentive objects; 1.11 Principle of repurchase and cancellation of restricted shares. 2. Proposal on the Management Measures for the Implementation and Assessment of the Company's 2016 Restricted Stock Incentive Plan; 3. Proposal on Submitting the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Equity Incentive. |
Deliberation content | |
|
Announcement date of notice of general meeting of shareholders: August 22, 2016 |
corporate name | Shutaishen |
Date of announcement | 2016-08-22 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | Proposal 1. Proposal on Repurchase and Cancellation of Some Granted but Unlocked Restricted Stocks Proposal 2. Proposal on Change of Registered Capital of the Company Proposal 3. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of the notice of the general meeting of shareholders: June 21, 2016 |
corporate name | Shutaishen |
Date of announcement | 2016-06-21 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on Using Idle Raised Funds for Cash Management 2. Proposal on Change of Registered Capital of the Company 3. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | |
|
Announcement date of the notice of the general meeting of shareholders: February 29, 2016 |
corporate name | Shutaishen |
Date of announcement | 2016-02-29 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on the 2015 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2. Proposal on 2015 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3. Proposal on 2015 Annual Financial Statement Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 4. Proposal on 2015 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biopharmaceutical Co., Ltd 5. Proposal on 2015 Profit Distribution and Capital Reserve Conversion to Share Capital Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 6. Proposal on the Company's Renewal of Employment of Accounting Firm 7. Proposal on Remuneration Plan of Directors and Supervisors in 2016 8. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of the notice of the general meeting of shareholders: November 30, 2015 |
corporate name | Shutaishen |
Date of announcement | 2015-11-30 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on By election of Mr. Zhao Jialiang as an Independent Director of the Third Board of Directors of the Company |
Deliberation content | |
|
Announcement date of the notice of the general meeting of shareholders: August 27, 2015 |
corporate name | Shutaishen |
Date of announcement | 2015-08-27 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting, soliciting votes |
Topic | 1. Proposal on the Election of Non independent Directors by the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 1.1 Elect Mr. Zhou Zhiwen as a director of the third Board of Directors of the Company 1.2 Elect Mr. Jiang Lixin as a director of the third board of directors of the company 1.3 Electing Ms. Zhou Yi as a director of the third Board of Directors 1.4 Elect Mr. Gu Zhenqi as a director of the third Board of Directors of the Company 1.5 Elect Mr. Chen Hao as a director of the third Board of Directors of the Company 1.6 Elect Mr. Duan Jidong as a director of the third board of directors of the company 2. Proposal on the Election of Independent Directors by the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2.1 Elect Mr. Wu Songsheng as the independent director of the third board of directors 2.2 Electing Mr. Gong Zhaolong as the independent director of the third board of directors 3. Proposal on the General Election of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 3.1 Elect Mr. Zhang Hongshan as the supervisor of the third Board of Supervisors 3.2 Electing Mr. Ye Qing as the supervisor of the third Board of Supervisors 4. Proposal on the Restricted Stock Incentive Plan (Draft) and its Abstract of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. (each sub proposal needs to be voted one by one) 4.1 Determination basis and scope of incentive objects; 4.2 Stock source and number of underlying stocks of the restricted stock incentive plan; 4.3 Distribution of restricted shares granted to incentive objects; 4.4 The validity period, grant date, lock up period, unlock date and lock up period of the restricted stock incentive plan; 4.5 The grant price of restricted shares and the method for determining the grant price; 4.6 Conditions for granting and unlocking restricted shares; 4.7 Adjustment methods and procedures of restricted stock incentive plan; 4.8 The principle of repurchase and cancellation of restricted shares; 4.9 Procedures for the Company to grant rights and unlock incentive objects; 4.10 Rights and obligations of the company and incentive objects; 4.11 Handling of changes in the company and incentive objects. 5. Proposal on the Stock Appreciation Right Incentive Plan (Draft) and its Abstract of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. (each sub proposal needs to be voted one by one) 5.1 Determination basis and scope of incentive objects; 5.2 The number of underlying stocks of the stock appreciation right incentive plan; 5.3 Distribution of stock appreciation rights granted to incentive objects; 5.4 Validity period, grant date, waiting period, exercise date and lock up period of stock appreciation right incentive plan; 5.5 The grant price of stock appreciation rights and the method for determining the grant price; 5.6 Conditions for the grant and exercise of stock appreciation rights; 5.7 Adjustment methods and procedures of stock appreciation right incentive plan; 5.8 Principle of cancellation of stock appreciation right; 5.9 Procedures for the Company to grant rights and interests and incentive objects to exercise rights; 5.10 Rights and obligations of the company and incentive objects; 5.11 Handling of changes in the company and incentive objects; 6. Proposal on the Measures for the Implementation and Assessment of the Equity Incentive Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 7. Proposal on Requesting the General Meeting of Shareholders of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. to Authorize the Board of Directors to Handle Matters Related to the Company's Equity Incentive Plan 8. Proposal on Adjusting the Allowance of Independent Directors of the Company |
Deliberation content | Proposal on the change of directors |
|
Announcement date of the notice of the general meeting of shareholders: February 16, 2015 |
corporate name | Shutaishen |
Date of announcement | 2015-02-16 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on the 2014 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 2. Proposal on the 2014 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 3. Proposal on 2014 Financial Final Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 4. Proposal on the 2014 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 5. Proposal on the Plan for 2014 Profit Distribution and Conversion of Capital Reserve into Capital Stock of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 6. Proposal on the Company's Renewal of Employment of Accounting Firm; 7. Proposal on Remuneration Plan of Directors and Supervisors in 2015; 8. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 9. Proposal on Amending the Rules of Procedure of the General Meeting of Shareholders. |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of the notice of the general meeting of shareholders: March 11, 2014 |
corporate name | Shutaishen |
Date of announcement | 2014-03-11 |
Meeting Type | Annual General Meeting |
Convening method | Online voting, on-site voting |
Topic | 1. Proposal on the 2013 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 2. Proposal on 2013 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 3. Proposal on 2013 Financial Final Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 4. Proposal on 2013 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 5. Proposal on 2013 Profit Distribution Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 6. Proposal on the Company's Renewal of Employment of Accounting Firm; 7. Proposal on Remuneration Plan of Directors and Supervisors in 2014; 8. Proposal on By election of Mr. Duan Jidong as a Director of the Second Board of Directors of the Company; 9. Proposal on Changing the Company's Domicile; 10. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of the notice of the general meeting of shareholders: March 10th, 2013 |
corporate name | Shutaishen |
Date of announcement | 2013-03-10 |
Meeting Type | Annual General Meeting |
Convening method | On site voting |
Topic | 1. Deliberate the Proposal on the 2012 Work Report of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 2. Deliberate the Proposal on the 2012 Work Report of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 3. Deliberate the Proposal on the 2012 Financial Final Report of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 4. Deliberate the Proposal on 2012 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biopharmaceutical Co., Ltd; 5. Deliberate the Proposal on 2012 Profit Distribution and Capital Reserve Conversion to Share Capital Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 6. Deliberate the Proposal on Renewing the Employment of Accounting Firm by the Company; 7. Deliberate the Proposal on Amending the Measures for the Administration of External Investment of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 8. Deliberate the Proposal on Amending the Working System of Independent Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 9. Proposal on the Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of the notice of the general meeting of shareholders: August 21, 2012 |
corporate name | Shutaishen |
Date of announcement | 2012-08-21 |
Meeting Type | interim general meeting of stockholders |
Convening method | Online voting, on-site voting, soliciting votes |
Topic | (1) Proposal on Remuneration and Performance Appraisal Management System for Directors, Supervisors and Senior Managers of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; (2) Proposal on Amendment to the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; (3) Proposal on the Equity Incentive Plan (Draft) of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. (each sub proposal needs to be considered item by item): 3.1 The purpose of the stock option incentive plan; 3.2 Management organization of stock option incentive plan; 3.3 Incentive objects of stock option incentive plan; 3.4 Specific contents of the stock option incentive plan; 3.5 Accounting treatment of stock option incentive plan and its impact on the company's performance; 3.6 Procedures for the Company to implement equity incentive plans, grant stock options and exercise incentive objects; 3.7 Rights and obligations of the company and incentive objects; 3.8 Change and termination of stock option incentive plan. (4) Proposal on Assessment Management Measures for the Implementation of Stock Option Incentive Plan of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; (5) Proposal on Submitting to the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Stock Option Incentive Plan. |
Deliberation content | |
|
Announcement date of the notice of the general meeting of shareholders: May 15, 2012 |
corporate name | Shutaishen |
Date of announcement | 2012-05-15 |
Meeting Type | interim general meeting of stockholders |
Convening method | On site voting |
Topic | 1. Deliberating the Proposal on the General Election of the Board of Directors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd 2. Deliberating the Proposal on the General Election of the Board of Supervisors of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd |
Deliberation content | Proposal on the change of directors |
|
Announcement date of the notice of the general meeting of shareholders: March 18th, 2012 |
corporate name | Shutaishen |
Date of announcement | 2012-03-18 |
Meeting Type | Annual General Meeting |
Convening method | On site voting |
Topic | 1. Deliberate the Proposal on the Work Report of the Board of Directors of the Company in 2011; 2. Deliberate the Proposal on the Work Report of the Board of Supervisors in 2011; 3. Deliberate the Proposal on the Company's 2011 Annual Financial Statement Report; 4. Deliberate the Proposal on 2011 Annual Report and Summary of Annual Report of Shutaishen (Beijing) Biopharmaceutical Co., Ltd; 5. Deliberate the Proposal on the Plan for Profit Distribution and Conversion of Capital Reserve into Share Capital of the Company in 2011; 6. Deliberate the Proposal on Renewing the Employment of Accounting Firm by the Company; 7. Deliberate the Proposal on Amending the Management Measures for External Investment of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd; 8. Deliberate the Proposal on Amending the Articles of Association of Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd. |
Deliberation content | Profit distribution plan, annual report (summary) proposal |
|
Announcement date of notice of general meeting of shareholders: November 22, 2011 |
corporate name | Shutaishen |
Date of announcement | 2011-11-22 |
Meeting Type | interim general meeting of stockholders |
Convening method | On site voting |
Topic | 1. Deliberating the Proposal on Electing Mr. Wu Songsheng as an Independent Director of the First Board of Directors of the Company 2. Deliberating the Proposal on Adjusting the Allowance of Independent Directors 3. Deliberating the Proposal on Changing the Accounting Firm |
Deliberation content | |
|